Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (101-110 of 170) with videos related to

Pageof 17
Sort By:
Scientific Reports|October 6, 2022
High risk of developing dementia in Parkinson's disease: a Swedish registry-based studyDaniel Oudin Åström, Jacob Simonsen, Lars Lau Raket, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Reduced body mass index in Parkinson's disease: contribution of comorbid depressionMaximilian Pilhatsch, Nils B Kroemer, Christine Schneider, et al.
Advances in Therapy|May 21, 2021
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic ReviewAngelo Antonini, Per Odin, Rajesh Pahwa, et al.
Palliative Medicine|December 6, 2023
A systematic practice review: Providing palliative care for people with Parkinson's disease and their caregiversMichela Garon, Christiane Weck, Kristina Rosqvist, et al.
Parkinsonism & Related Disorders|March 5, 2013
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal deliveryThomas Müller, Teus van Laar, David R Cornblath, et al.
Journal of Religion and Health|December 4, 2023
Meaning in Life in Late-Stage Parkinson's Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European CountriesSarah K Bublitz, Cornelia Brandstötter, Martin Fegg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2009
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of lifeHolger Honig, Angelo Antonini, Pablo Martinez-Martin, et al.
NPJ Parkinson'S Disease|June 27, 2017
Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scalePablo Martinez-Martin, Jose Manuel Rojo-Abuin, Alexandra Rizos, et al.
Journal of Geriatric Psychiatry and Neurology|October 23, 2020
Caregiver Burden in Late-Stage Parkinsonism and Its AssociationsStefania Kalampokini, Adrianus L A J Hommel, Stefan Lorenzl, et al.
Expert Opinion on Drug Delivery|July 30, 2025
Navigating the therapeutic landscape in advanced Parkinson's disease: a comprehensive review from infusion therapies to stem cellsCarmelo Fogliano, Leonardo Rigon, K Ray Chaudhuri, et al.
Pageof 17

Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
Scientific Reports|October 6, 2022
High risk of developing dementia in Parkinson's disease: a Swedish registry-based studyDaniel Oudin Åström, Jacob Simonsen, Lars Lau Raket, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Reduced body mass index in Parkinson's disease: contribution of comorbid depressionMaximilian Pilhatsch, Nils B Kroemer, Christine Schneider, et al.
Advances in Therapy|May 21, 2021
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic ReviewAngelo Antonini, Per Odin, Rajesh Pahwa, et al.
Palliative Medicine|December 6, 2023
A systematic practice review: Providing palliative care for people with Parkinson's disease and their caregiversMichela Garon, Christiane Weck, Kristina Rosqvist, et al.
Parkinsonism & Related Disorders|March 5, 2013
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal deliveryThomas Müller, Teus van Laar, David R Cornblath, et al.
Journal of Religion and Health|December 4, 2023
Meaning in Life in Late-Stage Parkinson's Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European CountriesSarah K Bublitz, Cornelia Brandstötter, Martin Fegg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2009
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of lifeHolger Honig, Angelo Antonini, Pablo Martinez-Martin, et al.
NPJ Parkinson'S Disease|June 27, 2017
Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scalePablo Martinez-Martin, Jose Manuel Rojo-Abuin, Alexandra Rizos, et al.
Journal of Geriatric Psychiatry and Neurology|October 23, 2020
Caregiver Burden in Late-Stage Parkinsonism and Its AssociationsStefania Kalampokini, Adrianus L A J Hommel, Stefan Lorenzl, et al.
Expert Opinion on Drug Delivery|July 30, 2025
Navigating the therapeutic landscape in advanced Parkinson's disease: a comprehensive review from infusion therapies to stem cellsCarmelo Fogliano, Leonardo Rigon, K Ray Chaudhuri, et al.
Pageof 17